65 results
Page 3 of 4
8-K
EX-99
7p27 au7k9g
12 Nov 19
Cue Biopharma Reports Third Quarter 2019 Financial Results
4:05pm
8-K
EX-1.1
3zk6rh4g axf18
5 Jun 19
Entry into a Material Definitive Agreement
8:55am
424B5
fsahw4mfcrrak
5 Jun 19
Prospectus supplement for primary offering
8:49am
424B3
jrcfc6bj eaj1kre
8 Feb 19
Prospectus supplement
4:16pm
S-3
fgbzysdxktucrgl678
4 Jan 19
Shelf registration
5:02pm
8-K/A
EX-10.1
llym4p9
26 Dec 18
Cue Biopharma and LG Chem Life Sciences Announce WT1
4:31pm
8-K/A
EX-99.1
5l0d82
26 Dec 18
Cue Biopharma and LG Chem Life Sciences Announce WT1
4:31pm
8-K/A
EX-10.1
saah6zhb
13 Nov 18
Entry into a Material Definitive Agreement
4:22pm
8-K
EX-99.1
ipqi yn1h
8 Nov 18
Entry into a Material Definitive Agreement
8:13am
424B3
qtnqlu7p6c8dpcy
23 Jul 18
Prospectus supplement
4:44pm
8-K
EX-99
4g989kt6e706l01axite
12 Jul 18
Cue Biopharma Produces Immuno-STATTM Biologic Candidate for Treatment of Autoimmune Disease Under Collaboration and License Agreement with Merck
8:40am
8-K
EX-10.1
eydxnjma6s
20 Jun 18
Entry into a Material Definitive Agreement
12:00am